Global Radiation Dose-Reduction System Market Is Likely To Grow At A CAGR Value Of Around 13.20 % By 2028

The global Radiation Dose-Reduction System market was worth around USD 249.50 billion in 2021 and is estimated to grow to about USD 524.99 billion by 2028, with a compound annual growth rate (CAGR) of approximately 13.20 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

A radiation dose-reduction system regulates numerous factors, such as the distance between the examination table and the tube head, to help reduce the amount of x-ray irradiated. The primary purpose of this technology's development is to make medical examinations safer for patients. As technology progresses, radiology departments are employing a variety of ways to reduce the intensity of X-Ray photons on the human body.

The global radiation dose management market revenue is being driven by a growing geriatric population, rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs) across the globe, rising awareness of early disease diagnosis and treatment, and an increase in the number of medical imaging and radiation procedures. The rapid adoption of technologically advanced medical imaging modalities such as computer tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), as well as rising concerns about sensitivity to radiation exposure, adverse health effects of radiation exposure in several cases, and the growing need for better radiation dose control and management, are all major factors driving global market revenue growth.

The market is divided into standalone solutions, integrated solutions, and services based on products and services. The standalone solutions sector is predicted to grow at the fastest rate over the forecast period. A major driver of this segment's growth is the increased adoption of radiation dose management solutions by healthcare providers as a result of tightening ionising radiation laws around the world.

The market is segmented into computed tomography, fluoroscopy, and interventional imaging, nuclear medicine, radiography, and mammography by modality. Computed tomography is predicted to increase at the fastest rate in the modality segment. Patients receiving computed tomography (CT) have been exposed to more radiation, resulting in burns and radiation sickness. Due to significant dose exposures during CT scans, manufacturers are adding technologies for precise dose prediction in the CT process. New CT equipment with dose reduction hardware and software reduces the risk of radiation exposure to patients. With Certegra and the Medrad Stellant CT injectable device, Bayer's Radimetric Enterprise Platform, for example, automates dose recording. The Canon Medical Systems Aquilion One/Genesis Edition CT can eliminate the need for multimodality investigations because it captures an image of the complete brain in a single 640-slice rotation. 

North America is having the largest share in the regional. According to a Harvard Medical School report, more than 80 million CT scans are performed each year in the United States. Scanning procedures such as CT angiography, colonography, and dual-energy and perfusion CT have altered diagnosis and therapy. However, high-dose radiation exposure is becoming a source of concern due to the dangers associated with ionising radiation. As a result, radiology departments are performing CT scans with low amounts of radiation. To produce precise radiation dose estimations that can be compared to reference standards, many research centres and hospitals are using current state-of-the-art CT equipment that is integrated with software and ERP systems. The dose tracking programme calculates the average dose based on previous CT examination doses.

 Key players functioning in the global Radiation Dose-Reduction System market include Bayer AG, Bracco Imaging SpA,Fujifilm Holdings Corporation,GE Healthcare, Medsquare, Novarad Corporation, PACShealth LLC, Koninklijke Philips N.V., Qaelum NV and Sectra AB.

Browse the full “Radiation Dose-Reduction System Market By Products & Services (Standalone Solutions, Integrated Solutions, Services), By Modality (Computed Tomography, Fluoroscopy and Interventional Imaging, Nuclear Medicine, Radiography and Mammography), By End User( Ambulatory Care Settings, Hospital, Other), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/radiation-dose-reduction-system-market

Global Radiation Dose-Reduction System market is segmented as follows:

By Products & Services

• Standalone Solutions
• Integrated Solutions
• Services

By Modality

• Computed Tomography
• Fluoroscopy and Interventional Imaging
• Nuclear Medicine
• Radiography and Mammography

By End User

• Ambulatory Care Settings
• Hospital
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com